Concepedia

Carolyn A. Buser

CA

57

Publications

5K

Citations

37

H-Index

1986

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

State University of New York

Yale University

National University of Singapore

Carolyn A. Buser is an author at United States Military Academy specializing in medicine, biochemistry, and drug discovery.

Top concepts

Publications per year

1986–2015

57

Publications

57

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

Wing‐Kin Sung, Hancheng Zheng, Shuyu Li et al. · Nature Genetics · 2012 · 981 citations

, , +5

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Robert B. Lobell, CharlesA. Omer, Marc Abrams et al. · PubMed · 2001 · 239 citations

, , +18

MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells

Kathleen A. Bridges, Hiroshi Hirai, Carolyn A. Buser et al. · Clinical Cancer Research · 2011 · 231 citations · Full text

Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids.

C T Sigal, Wenjun Zhou, Carolyn A. Buser et al. · Proceedings of the National Academy of Sciences · 1994 · 230 citations · Full text

, , +15

Myristoylated Alanine-rich C Kinase Substrate (MARCKS) Produces Reversible Inhibition of Phospholipase C by Sequestering Phosphatidylinositol 4,5-Bisphosphate in Lateral Domains

Michael Gläser, Stephen Wanaski, Carolyn A. Buser et al. · Journal of Biological Chemistry · 1996 · 225 citations · Full text

Rows per page

1–5 of 57